Long Term Follow-Up of Sulfur Mustard Related Bronchiolitis Obliterans Treatment

Bronchiolitis obliterans (BO) is the most remarkable pulmonary sequels of war-related sulfur mustard inhalation. There is little if any data about long-term efficacy of associated BO treatment. Five years spirometric records of three groups of patients with obstructive pulmonary diseases (asthma, CO...

Full description

Bibliographic Details
Main Authors: Hamidreza Abtahi, Soheil Peiman, Morteza Foroumandi, Enayat Safavi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2016-10-01
Series:Acta Medica Iranica
Subjects:
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/5193
_version_ 1818644108722307072
author Hamidreza Abtahi
Soheil Peiman
Morteza Foroumandi
Enayat Safavi
author_facet Hamidreza Abtahi
Soheil Peiman
Morteza Foroumandi
Enayat Safavi
author_sort Hamidreza Abtahi
collection DOAJ
description Bronchiolitis obliterans (BO) is the most remarkable pulmonary sequels of war-related sulfur mustard inhalation. There is little if any data about long-term efficacy of associated BO treatment. Five years spirometric records of three groups of patients with obstructive pulmonary diseases (asthma, COPD, BO) and documented sulfur mustard inhalation were evaluated. The BO patients were treated with inhaled Seretide 125-250/25 (2 puffs BID), azithromycin (250 mg, three times/week) and N-acetylcysteine (1200-1800/day). Asthma and COPD patients were treated according to existing guidelines. Seventy-three (38 asthma, 16 COPD and 19 BO) patients completed the 5 years follow-up. Basal and final FEV1 in BO patients (2.69±0.81 and 2.39±0.65 respectively) were not significantly different from COPD patients (2.46±0.56 and 1.96±0.76 respectively). There was also no significant difference between the yearly FEV1 decline in BO patients compared to COPD patients (60±84 cc vs. 99±79 cc respectively, P=0.163). The non-significant difference of FEV1 decline in BO compared to COPD patients suggests the effectiveness of azithromycin, inhaled steroid and N-acetyl cysteine in BO patients. Considering safety and possible effectiveness, this treatment is recommended until more data is available from controlled clinical studies.
first_indexed 2024-12-17T00:09:37Z
format Article
id doaj.art-4f42ee39f3b9433ebd8d07033ff8b171
institution Directory Open Access Journal
issn 0044-6025
1735-9694
language English
last_indexed 2024-12-17T00:09:37Z
publishDate 2016-10-01
publisher Tehran University of Medical Sciences
record_format Article
series Acta Medica Iranica
spelling doaj.art-4f42ee39f3b9433ebd8d07033ff8b1712022-12-21T22:10:51ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942016-10-015495047Long Term Follow-Up of Sulfur Mustard Related Bronchiolitis Obliterans TreatmentHamidreza Abtahi0Soheil Peiman1Morteza Foroumandi2Enayat Safavi3Department of Pulmonary and Critical Care, Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran. AND department of Pulmonary and Critical Care, Imam Khomeini Medical Center, Tehran University of Medical Sciences, Tehran, Iran.Department of Pulmonary and Critical Care, Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran.AND Department of Internal Medicine, Imam Khomeini Medical Center, Tehran University of Medical Sciences, Tehran, Iran.Department of Internal Medicine, Imam Khomeini Medical Center, Tehran University of Medical Sciences, Tehran, Iran.Department of Pulmonary and Critical Care, Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Pulmonary and Critical Care, Imam Khomeini Medical Center, Tehran University of Medical Sciences, Tehran, Iran.Bronchiolitis obliterans (BO) is the most remarkable pulmonary sequels of war-related sulfur mustard inhalation. There is little if any data about long-term efficacy of associated BO treatment. Five years spirometric records of three groups of patients with obstructive pulmonary diseases (asthma, COPD, BO) and documented sulfur mustard inhalation were evaluated. The BO patients were treated with inhaled Seretide 125-250/25 (2 puffs BID), azithromycin (250 mg, three times/week) and N-acetylcysteine (1200-1800/day). Asthma and COPD patients were treated according to existing guidelines. Seventy-three (38 asthma, 16 COPD and 19 BO) patients completed the 5 years follow-up. Basal and final FEV1 in BO patients (2.69±0.81 and 2.39±0.65 respectively) were not significantly different from COPD patients (2.46±0.56 and 1.96±0.76 respectively). There was also no significant difference between the yearly FEV1 decline in BO patients compared to COPD patients (60±84 cc vs. 99±79 cc respectively, P=0.163). The non-significant difference of FEV1 decline in BO compared to COPD patients suggests the effectiveness of azithromycin, inhaled steroid and N-acetyl cysteine in BO patients. Considering safety and possible effectiveness, this treatment is recommended until more data is available from controlled clinical studies.https://acta.tums.ac.ir/index.php/acta/article/view/5193BioterrorismBronchiolitisSulfur mustardMacrolideTreatment
spellingShingle Hamidreza Abtahi
Soheil Peiman
Morteza Foroumandi
Enayat Safavi
Long Term Follow-Up of Sulfur Mustard Related Bronchiolitis Obliterans Treatment
Acta Medica Iranica
Bioterrorism
Bronchiolitis
Sulfur mustard
Macrolide
Treatment
title Long Term Follow-Up of Sulfur Mustard Related Bronchiolitis Obliterans Treatment
title_full Long Term Follow-Up of Sulfur Mustard Related Bronchiolitis Obliterans Treatment
title_fullStr Long Term Follow-Up of Sulfur Mustard Related Bronchiolitis Obliterans Treatment
title_full_unstemmed Long Term Follow-Up of Sulfur Mustard Related Bronchiolitis Obliterans Treatment
title_short Long Term Follow-Up of Sulfur Mustard Related Bronchiolitis Obliterans Treatment
title_sort long term follow up of sulfur mustard related bronchiolitis obliterans treatment
topic Bioterrorism
Bronchiolitis
Sulfur mustard
Macrolide
Treatment
url https://acta.tums.ac.ir/index.php/acta/article/view/5193
work_keys_str_mv AT hamidrezaabtahi longtermfollowupofsulfurmustardrelatedbronchiolitisobliteranstreatment
AT soheilpeiman longtermfollowupofsulfurmustardrelatedbronchiolitisobliteranstreatment
AT mortezaforoumandi longtermfollowupofsulfurmustardrelatedbronchiolitisobliteranstreatment
AT enayatsafavi longtermfollowupofsulfurmustardrelatedbronchiolitisobliteranstreatment